The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

Table 4

Number of grafts without and with mild and moderate macrovesicular steatosis.

	Macrovesicular steatosis
	None	Mild	Moderate
	(0%)	(1–30%)	(31–60%)
Sevoflurane group, 𝑛	9	16	5
Control group, 𝑛	9	15	6